Group 1: Automotive Industry - Nvidia launched the Alpamayo inference driving model at CES 2026, featuring a 100 billion parameter end-to-end VLA (Vision-Language-Action) model, which enhances the reasoning capabilities for novel scenarios and provides interpretability for driving decisions [5][10] - The introduction of simulation tools like AlpaSim and a 1700-hour physical AI open dataset supports autonomous driving training and testing, aiming to create a comprehensive autonomous driving solution [10][11] - The demand for autonomous driving features is increasing, becoming essential for consumers when choosing vehicles, with expectations for L2++ and L4 Robotaxi technologies to proliferate globally [12][11] Group 2: Electronics Industry - The consumer electronics and components sector showed significant performance improvement in 2025, with the PCB industry leading in growth due to rapid iterations and shipments of AI products [6][15] - Traditional categories like smartphones and PCs maintained stable growth, while AI glasses and AI servers exhibited rapid growth trends [16][19] - Investment strategies for 2026 focus on key players in the Apple, Huawei HarmonyOS, AI glasses, and OpenAI hardware sectors, indicating a new cycle of innovation in consumer electronics [17][20] Group 3: Chemical Industry - Salt Lake Co. reported an expected net profit of 82.9-88.9 billion yuan for 2025, a year-on-year increase of 77.78%-90.65%, driven by the recovery in potassium and lithium prices [22][24] - The company plans to acquire a 51% stake in Minmetals Salt Lake to expand its potassium and lithium resources, with projected net profits for 2025-2027 revised upwards [23][24] - The production of potassium chloride is expected to be approximately 4.9 million tons in 2025, while lithium carbonate production is projected at 46,500 tons, reflecting a strategic focus on resource control and high-quality development [24][22] Group 4: Investment Recommendations - The automotive sector is advised to focus on companies like Desay SV, Huayang Group, and XPeng Motors, which are expected to benefit from advancements in autonomous driving technology [13] - In the electronics sector, companies such as Industrial Fulian, Luxshare Precision, and GoerTek are highlighted as beneficiaries of the AI computing and terminal resonance [20][19] - Salt Lake Co. is recommended for investment due to its strong market position in potassium and lithium resources and the anticipated growth from the acquisition of Minmetals Salt Lake [23][22]

Group 1 - The report highlights the significant progress in the pharmaceutical and healthcare system reforms during the "14th Five-Year Plan" period, with a focus on grassroots healthcare and urban-rural integration [1][12] - The "15th Five-Year Plan" emphasizes the support for innovative drugs and medical devices, aiming to enhance the healthcare system and promote the development of traditional Chinese medicine [1][17] - The report indicates that the 11th batch of national drug procurement successfully implemented innovative goals, including maintaining clinical stability and quality assurance [1][14] Group 2 - As of December 31, 2025, the total market capitalization of 21 pharmaceutical and biotechnology companies on the North Exchange reached 748.30 billion, reflecting a growth of 45.81% from the beginning of the year [2][20] - The average market capitalization of these companies increased to 35.63 billion, up 38.87% from the previous year [2][21] - The North Exchange's pharmaceutical sector is primarily composed of chemical pharmaceuticals (38.10%), medical devices (28.57%), and biological products (19.05%) [2][31] Group 3 - In 2025, the North Exchange's pharmaceutical and biotechnology sector experienced a year-on-year increase of 37.38%, ranking third among various sectors [3][54] - The report notes that 80.95% of the pharmaceutical companies on the North Exchange saw an increase in their stock prices throughout the year [3][42] - The top-performing companies in terms of stock price growth included JinHao Medical (+174.08%), NuoSiLanDe (+105.64%), and BeiYiKang (+76.39%) [3][45] Group 4 - The report indicates that the North Exchange's pharmaceutical companies had a PE TTM average of 73X by the end of 2025, with a peak of 119X in August [2][34] - The distribution of valuations shows that the North Exchange has a higher proportion of companies with significant losses compared to other exchanges, with 28.57% of companies in the loss category [2][40] - The report highlights that the North Exchange's pharmaceutical sector is characterized by a high concentration of companies in the 100X and above PE TTM range [2][43]

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Insights - The report highlights the significant advantages of robotics in enhancing the growth potential of automotive companies, particularly in the context of the ongoing transition to electric vehicles and autonomous driving technologies [3][6] - The introduction of Nvidia's Alpamayo model and its open-source tools is expected to accelerate the maturity and deployment of autonomous driving technologies, making it easier for developers to create and implement advanced driving algorithms [5][6] - The demand for intelligent driving features is becoming a critical factor for consumers when choosing vehicles, with expectations for these features to penetrate mid- to high-end models [7] Summary by Sections Industry Overview - The intelligent driving sector is poised for continued growth in 2026, driven by both supply and demand factors [7] - Nvidia's advancements in AI and autonomous driving are expected to lower development barriers and enhance the ecosystem for autonomous vehicle deployment [6] Key Opportunities - The report suggests focusing on companies within the intelligent driving supply chain, including Desay SV, Huayang Group, and XPeng Motors, among others, which are likely to benefit from the growth in this sector [8] - Specific beneficiaries identified include companies like Cobot, Bertel, and Horizon Robotics, which are positioned to capitalize on the advancements in intelligent driving technologies [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported better-than-expected performance for 2025, with a projected net profit attributable to shareholders of 82.9-88.9 billion yuan, representing a year-on-year growth of 77.78%-90.65%. The fourth quarter net profit is expected to be 37.9-43.9 billion yuan, showing a year-on-year increase of 148.9%-188.3% and a quarter-on-quarter increase of 90.5%-120.7% [3][4] - The company plans to acquire a 51% stake in Minmetals Salt Lake for 4.605 billion yuan, which is expected to enhance its potassium and lithium resource control [4][7] - The company is expected to benefit from the recovery in potassium and lithium prices, as well as the confirmation of deferred tax assets, leading to an upward revision of profit forecasts for 2025-2027 [3][4] Financial Summary - The company expects to achieve operating revenue of 163.17 billion yuan in 2025, with a year-on-year growth of 7.8%. The net profit attributable to shareholders is projected to be 85.57 billion yuan in 2025, with an EPS of 1.62 yuan per share [5][12] - The gross margin is expected to improve to 63.8% in 2025, while the net margin is projected to be 52.4% [5][12] - The company’s total market capitalization is approximately 171.29 billion yuan, with a current price-to-earnings ratio (P/E) of 20.0 for 2025 [1][5] Production and Sales Data - In 2025, the company’s potassium chloride production is estimated at 4.9 million tons, a slight decrease of 1.2% year-on-year, while lithium carbonate production is expected to increase by 16.2% to 46,500 tons [4][9] - The average price for potassium chloride is projected to be 3,002 yuan per ton in 2025, reflecting a year-on-year increase of 21.5%, while lithium carbonate prices are expected to decline [4][9] Acquisition Impact - Following the acquisition of Minmetals Salt Lake, the company’s potassium chloride and lithium carbonate production capacity is expected to expand significantly, with a long-term goal of reaching 10 million tons per year for potassium chloride and 200,000 tons per year for lithium salts by 2030 [7][8] - Minmetals Salt Lake has proven reserves of 1.463 million tons of potassium chloride and 164,590 tons of lithium chloride, which will enhance the company's resource base [4][7]

Group 1: Non-Bank Financial Sector - The insurance sector is expected to enter a "golden development cycle" as the proportion of insurance in residents' financial management continues to rise, driven by the dual advantages of savings and protection [3][8][9] - The transformation of dividend insurance is enhancing product attractiveness, with demand for pension and health protection steadily increasing, and the supply of large-denomination certificates of deposit shrinking [8][10] - By 2026, new individual insurance policies are anticipated to stabilize and grow, benefiting from the performance of leading insurance companies and the improvement in new business value (NBV) growth [3][8][10] Group 2: Medical Sector - Brain-Computer Interface (BCI) - The brain-computer interface (BCI) technology is undergoing rapid transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each with its own advantages [4][12][15] - The Chinese BCI market is projected to reach approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market, with significant growth potential in medical applications [14][15] - Policy support is crucial for the BCI industry, with initiatives aimed at establishing standards and payment systems to facilitate clinical applications and reduce costs [14][15] Group 3: Media Sector - Gaming Companies - The gaming company is demonstrating confidence through a share buyback of up to 400 million HKD, with expectations for revenue growth driven by upcoming game launches and seasonal events [5][18][21] - The company has adjusted its net profit forecasts for 2025-2027, reflecting a focus on game reserves and the growth potential of its TapTap and ADN businesses [5][18] - The upcoming high-profile game releases and improvements in advertising algorithms are expected to enhance user engagement and revenue growth for TapTap [18][21] Group 4: Sports Sector - Racing Industry - The racing company is positioned as a leader in the racing services sector, with a diversified sports layout expected to accelerate growth, supported by its experience in event operations and venue management [6][22][23] - The company is set to leverage its unique international racing venues, particularly in Hainan, to capitalize on the growing popularity of motorsports in China [22][23] - The expansion into golf and other sports is anticipated to create a second growth curve, aligning with national policies promoting sports development [22][24]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company announced a share buyback of up to HKD 400 million over five months, reflecting confidence in long-term development [5] - The upcoming holiday season is expected to boost revenue for the core product "Heart Town," with the international version set to launch on January 8, 2026, and has already garnered over one million global pre-registrations [5] - The company is optimistic about growth driven by festive events, regional expansion, and new game launches, with several high-profile mobile and PC games expected to launch in 2026 [5] - The performance of the game "Iser" in the domestic market has led to a downward revision of net profit forecasts for 2025-2027 [5] Financial Summary and Valuation Metrics - Revenue projections are as follows: - 2023: HKD 3,389 million - 2024: HKD 5,012 million - 2025: HKD 6,353 million - 2026: HKD 7,620 million - 2027: HKD 8,441 million - Year-over-year growth rates for revenue are projected at: - 2024: 47.9% - 2025: 26.7% - 2026: 20.0% - 2027: 10.8% [8] - Net profit projections are as follows: - 2023: -HKD 554 million - 2024: HKD 812 million - 2025: HKD 1,507 million - 2026: HKD 2,006 million - 2027: HKD 2,387 million - Year-over-year growth rates for net profit are projected at: - 2024: 1077.3% - 2025: 85.7% - 2026: 33.2% - 2027: 19.0% [8] - The current price-to-earnings (P/E) ratios are projected as follows: - 2025: 20.8 - 2026: 15.6 - 2027: 13.1 [8]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The insurance industry is expected to enter a "golden development cycle" driven by the transformation of participating insurance, increasing demand for pension and health protection, and the shrinking supply of large-denomination certificates of deposit [3][4] - In 2026, the new business value (NBV) growth of insurance companies is anticipated to improve significantly due to the recovery of individual insurance new orders and the favorable growth of new premium income [3][4] - The long-end interest rates are expected to rise steadily, benefiting the valuation of insurance companies and supporting their investment returns and high return on equity (ROE) [3][4] Summary by Sections 1. Insurance Assets and Resident Savings - The proportion of insurance assets in residents' savings and fixed-income financial assets has been continuously increasing, with total premium share rising from 15.8% in 2022 to 22.4% in 2025 [4][20] - By November 2025, the total premium scale reached 35.8 trillion, while resident deposits stood at 163.3 trillion [12][4] 2. Outlook for the Insurance Industry - The transformation of participating insurance is expected to enhance product competitiveness, with the average demonstration interest rate for new products in 2026 projected to be between 3.3% and 3.9% [35] - The aging population is driving demand for pension savings and health protection, establishing a solid foundation for the insurance industry's growth [30][31] 3. Investment Recommendations - Recommended stocks include China Pacific Insurance for its undervaluation and comprehensive advantages, Ping An for its strengths in the pension and health industry chain, and China Life for its distinct life insurance characteristics [3][45] - The report anticipates that the insurance asset scale will reach approximately 42.7 trillion by 2026, reflecting a year-on-year growth of 16.7% [42]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The brain-computer interface (BCI) technology is undergoing a period of accelerated transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each with its own advantages in signal quality, safety, and operational difficulty [5][19] - The Chinese brain-computer interface market is projected to grow significantly, with the market size reaching approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market [6] - The industry is supported by a three-pronged policy approach focusing on planning, payment, and standards, which is expected to facilitate rapid development [6][33] Summary by Sections 1. Brain-Computer Interface Overview - BCI is a multidisciplinary technology that integrates neuroscience, computer science, and engineering to enable communication between the brain and external devices [17] - The technology operates through a closed-loop system involving signal input, processing, device control, and feedback [17] 2. Policy Support for BCI Development - The Chinese government has issued several policies to support the BCI industry, including the "Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry" which outlines goals for 2027 and 2030 [6][43] - The policies aim to establish a robust industrial ecosystem, enhance innovation capabilities, and promote clinical applications of BCI technologies [43][44] 3. Technological Advancements and Applications - Core technological breakthroughs are occurring in the upstream segment of the BCI industry, particularly in hardware such as electrodes and chips [7] - The medical application of BCI is predominant, with 56% of the market share in 2023, focusing on various therapeutic areas including cognitive disorders and movement disabilities [7][9] - Companies like Lepu Medical and Aipeng Medical are actively involved in developing deep brain stimulation (DBS) technologies, with some preparing for IPOs [7][8] 4. Investment Recommendations - The report suggests focusing on both invasive and non-invasive BCI products, with specific companies identified as beneficiaries based on their clinical trial progress and commercialization potential [8] - Notable companies include Aipeng Medical and Lepu Medical for invasive products, and Xiangyu Medical and Innovation Medical for non-invasive products [8]

Macro Overview - The National Development and Reform Commission has announced the early batch of "two heavy" projects and central budget investment plans for 2026, totaling approximately 295 billion yuan, with 220 billion yuan allocated for infrastructure projects [9][10] - The government is focusing on enhancing domestic demand, increasing investment in new productive forces, and promoting employment and income growth [10][11] Industry Insights Media - The gaming sector is identified as a significant application area for brain-computer interfaces (BCIs), with potential for growth as technology matures [30] - Companies like 37 Interactive Entertainment and Century Huatong are actively investing in BCI-related projects, indicating a trend towards integrating gaming with advanced technologies [30][32] Defense and Aerospace - The military industry index has seen a 9.24% increase, outperforming the broader market, with current PE-TTM at 78.44 times, indicating a relatively high valuation [34] - Recent geopolitical events, including U.S. military actions in Venezuela, are expected to impact the defense sector positively [34][35] Automotive - The automotive supply chain is well-positioned for the development of humanoid robots, leveraging existing technologies and manufacturing capabilities [39] - Companies like Tesla are leading in humanoid robot development, with significant advancements expected in 2026 [40][41] - The valuation of automotive companies is shifting towards a technology-driven model, reflecting their growing focus on AI and robotics [41][42] Chemical Industry - The company is projected to achieve a net profit of 96 to 110 million yuan in 2025, representing a year-on-year growth of 50.6% to 72.56% [53] - The domestic potassium carbonate market is expected to see improved profitability due to a favorable supply-demand balance [54] - The company is also investing in the production of PEEK, a high-performance polymer, which could enhance its growth potential [57] Retail and Consumer Services - The retail sector is experiencing significant growth, with companies like Hema and Sam's Club expanding rapidly [50][51] - The tourism sector showed strong performance during the New Year holiday, with a notable increase in domestic travel and spending [47][48]

Quantitative Models and Construction Methods Model Name: Hong Kong Stock Connect CCASS Preferred 20 Portfolio - **Model Construction Idea**: The model uses Hong Kong Stock Exchange CCASS data to track and replicate the monthly holdings of individual brokers, selecting high-performing brokers and their top holdings to construct a portfolio[4][34] - **Model Construction Process**: 1. **Broker Selection**: At the end of each month, all brokers are ranked based on their standardized excess Sharpe ratio and monthly win rate, and the top N brokers are selected to form a pool of high-performing brokers[34] 2. **Stock Selection**: Funds are equally allocated to the N brokers, and their latest holdings are aggregated. The top M stocks by weight are retained and equally weighted to form the portfolio[34] 3. **Parameters**: N = 10 (number of brokers), M = 20 (number of stocks)[34] - **Model Evaluation**: The model has shown strong performance with high excess returns and Sharpe ratios, indicating its effectiveness in selecting high-performing stocks[34][36] Model Backtesting Results Hong Kong Stock Connect CCASS Preferred 20 Portfolio - **December 2025 Performance**: Portfolio return of 0.91%, Hang Seng Index return of -0.88%, excess return of 1.79%[36] - **Annual Performance 2025**: Portfolio return of 49.9%, annualized excess return of 17.8%[36] - **Full Period Performance (2020.1~2025.12)**: Annualized excess return of 20.0%, excess Sharpe ratio of 2.52[36] Quantitative Factors and Construction Methods Factor Name: Excess Sharpe Ratio and Monthly Win Rate - **Factor Construction Idea**: These factors are used to evaluate and rank brokers based on their risk-adjusted returns and consistency in generating positive returns[34] - **Factor Construction Process**: 1. **Excess Sharpe Ratio**: Calculated as the ratio of excess return to excess volatility for each broker[34] 2. **Monthly Win Rate**: The proportion of months in which the broker's portfolio outperforms the benchmark[34] 3. **Standardization**: Both factors are standardized and equally weighted to form a composite score for ranking brokers[34] - **Factor Evaluation**: These factors effectively identify brokers with superior risk-adjusted performance and consistency, contributing to the overall success of the portfolio[34] Factor Backtesting Results Excess Sharpe Ratio and Monthly Win Rate - **Top Brokers Performance**: - **Phillip Securities (Hong Kong)**: Annualized excess return of 10.4%, excess Sharpe ratio of 1.73, monthly win rate of 73.61%[35] - **GF Securities**: Annualized excess return of 12.9%, excess Sharpe ratio of 1.29, monthly win rate of 79.17%[35] - **Grand Partners Securities**: Annualized excess return of 18.1%, excess Sharpe ratio of 1.65, monthly win rate of 73.61%[35] Portfolio Holdings for January 2026 - **Top Holdings**: - **Tencent Holdings (0700.HK)**: PEttm 22.9, ROEttm 4.7%, Market Cap 54630.2 billion HKD[40] - **Xiaomi Corporation (1810.HK)**: PEttm 21.2, ROEttm 5.1%, Market Cap 10236.6 billion HKD[40] - **SMIC (0981.HK)**: PEttm 118.5, ROEttm 0.9%, Market Cap 7006.8 billion HKD[40] - **Hong Kong Exchanges and Clearing (0388.HK)**: PEttm 30.0, ROEttm 7.7%, Market Cap 5167.7 billion HKD[40] - **Ping An Insurance (2318.HK)**: PEttm 7.7, ROEttm 2.9%, Market Cap 12924.9 billion HKD[40]